Biosynex - Asset Resilience Ratio

Latest as of June 2025: 3.35%

Biosynex (ALBIO) has an Asset Resilience Ratio of 3.35% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Biosynex to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€5.00 Million

≈ $5.85 Million USD Cash + Short-term Investments

Total Assets

€149.44 Million

≈ $174.71 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2024)

This chart shows how Biosynex's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Biosynex total assets.

Liquid Assets Composition Over Time

This chart breaks down Biosynex's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Biosynex (ALBIO) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€5.00 Million	3.35%
Total Liquid Assets	€5.00 Million	3.35%

Asset Resilience Insights

Limited Liquidity: Biosynex maintains only 3.35% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Biosynex Industry Peers by Asset Resilience Ratio

Compare Biosynex's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Yuyue Medical Equipment & Supply Co Ltd SHE:002223	Medical Devices	0.84%
Shandong Weigao Orthopaedic Device Co. Ltd. A SHG:688161	Medical Devices	6.28%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	34.37%
Ningbo David Medical Device Co Ltd SHE:300314	Medical Devices	5.11%
Beijing Succeeder Technology Inc SHG:688338	Medical Devices	28.27%
Dirui Industrial Co Ltd SHE:300396	Medical Devices	3.90%
Profound Medical Corp TO:PRN	Medical Devices	67.66%
Affluent Medical SAS PA:AFME	Medical Devices	0.03%

Annual Asset Resilience Ratio for Biosynex (2011–2024)

The table below shows the annual Asset Resilience Ratio data for Biosynex.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.57%	€5.00 Million ≈ $5.85 Million	€194.69 Million ≈ $227.61 Million	+0.09pp
2023-12-31	2.48%	€6.00 Million ≈ $7.01 Million	€241.73 Million ≈ $282.61 Million	+2.48pp
2022-12-31	0.00%	€1.00 ≈ $1.17	€259.98 Million ≈ $303.94 Million	-0.90pp
2021-12-31	0.90%	€2.42 Million ≈ $2.83 Million	€268.94 Million ≈ $314.42 Million	-3.21pp
2020-12-31	4.11%	€5.18 Million ≈ $6.06 Million	€126.07 Million ≈ $147.39 Million	+1.54pp
2019-12-31	2.57%	€1.22 Million ≈ $1.42 Million	€47.34 Million ≈ $55.35 Million	+1.92pp
2018-12-31	0.65%	€257.50K ≈ $301.04K	€39.46 Million ≈ $46.14 Million	-4.33pp
2017-12-31	4.98%	€2.02 Million ≈ $2.36 Million	€40.51 Million ≈ $47.36 Million	+3.46pp
2016-12-31	1.52%	€599.22K ≈ $700.55K	€39.51 Million ≈ $46.19 Million	-23.11pp
2013-12-31	24.63%	€1.80 Million ≈ $2.10 Million	€7.31 Million ≈ $8.55 Million	-10.98pp
2012-12-31	35.61%	€3.15 Million ≈ $3.68 Million	€8.85 Million ≈ $10.34 Million	-35.56pp
2011-12-31	71.16%	€4.33 Million ≈ $5.06 Million	€6.09 Million ≈ $7.12 Million	--

pp = percentage points

About Biosynex

PA:ALBIO France Medical Devices

Market Cap

$19.39 Million

€16.59 Million EUR

Market Cap Rank

#25945 Global

#425 in France

Share Price

€0.90

Change (1 day)

-1.10%

52-Week Range

€0.48 - €1.57

All Time High

€25.28